Effector function of diabetogenic CD4 Th1 T cell clones: A central role for TNF-α

Journal of Immunology

Volumn 175, Issue 11, 2005, Pages 7738-7745

  Cantor, Joseph ^a   Haskins, Kathryn ^a,b  

^a UNIVERSITY OF COLORADO DENVER   (United States)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOKINE; CYTOKINE RECEPTOR; GAMMA INTERFERON; MESSENGER RNA; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CYTOKINE PRODUCTION; DIABETES MELLITUS; EFFECTOR CELL; EX VIVO STUDY; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; PANCREAS; PATHOGENESIS; PRIORITY JOURNAL; RECEPTOR UPREGULATION; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TH1 CELL;

EID: 28244436716     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.11.7738     Document Type: Article

References (23)

1. Haskins, K. 2005. Pathogenic T-cell clones in autoimmune diabetes: more lessons from the NOD mouse. Adv. Immunol. 87: 123-162.
2. Bradley, L. M., V, C. Asensio, L. K. Schioetz, J. Harbertson, T. Krahl, G. Patstone, N. Woolf, I. L. Campbell, and N. Sarvetnick. 1999. Islet-specific Th1, but not Th2, cells secrete multiple chemokines and promote rapid induction of autoimmune diabetes. J. Immunol. 162: 2511-2520.
3. Peixoto, A., M. Monteiro, B. Rocha, and H. Veiga-Femandes. 2004. Quantification of multiple gene expression in individual cells. Genome Res. 14: 1938-1947.
4. Roman, E., E. Miller, A. Harmsen, J. Wiley, U. H. Von Andrian, G. Huston, and S. L. Swain. 2002. CD4 effector T cell subsets in the response to influenza: heterogeneity, migration, and function. J. Exp. Med. 196: 957-968.
5. Haskins, K., M. Portas, B. Bradley, D. Wegmann, and K. Lafferty. 1988. T-lymphocyte clone specific for pancreatic islet antigen. Diabetes 37: 1444-1448.
6. Haskins, K., M. Portas, B. Bergman, K. Lafferty, and B. Bradley. 1989. Pancreatic islet-specific T-cell clones from nonobese diabetic mice. Proc. Natl. Acad. Sci. USA 86: 8000-8004.
7. Bergman, B., and K. Haskins. 1994. Islet-specific T-cell clones from the NOD mouse respond to β-granule antigen. Diabetes 43: 197-203.
8. Pauza, M. E., C. M. Dobbs, J. He, T. Patterson, S. Wagner, B. S. Anobile, B. J. Bradley, D. Lo, and K. Haskins. 2004. T-cell receptor transgenic response to an endogenous polymorphic autoantigen determines susceptibility to diabetes. Diabetes 53: 978-988.
9. Dorner, B. G., S. Steinbach, M. B. Huser, R. A. Kroczek, and A. Scheffold. 2003. Single-cell analysis of the murine chemokines MIP-1-α, MIP-1β, RANTES and ATAC/lymphotactin by flow cytometry. J. Immunol. Methods 274: 83-91.
10. Poulin, M., and K. Haskins. 2000. Induction of diabetes in nonobese diabetic mice by Th2 T cell clones from a TCR transgenic mouse. J. Immunol 164: 3072-3078.
11. Yoon, J. W., H. S. Jun, and P. Santamaria. 1998. Cellular and molecular mechanisms for the initiation and progression of β cell destruction resulting from the collaboration between macrophages and T cells. Autoimmunity 21: 109-122.
12. Mosser, D. M. 2003. The many faces of macrophage activation. J. Leukocyte Biol. 73: 209-212.
13. Suk, K., S. Kim, Y. H. Kim, K. A. Kim, I. Chang, H. Yagita, M. Shong, and M. S. Lee. 2001. IFN-γ/TNF-α synergism as the final effector in autoimmune diabetes: a key role for STAT1/IFN regulatory factor-1 pathway in pancreatic β cell death. J. Immunol. 166: 4481-4489.
14. Black, R. A. 2002. Tumor necrosis factor-α converting enzyme. Int. J. Biochem. Cell Biol. 34: 1-5.
15. Grell, M., E. Douni, H. Wajant, M. Lohden, M. Clauss, B. Maxeiner, S. Georgopoulos, W. Lesslauer, G. Kollias, K. Pfizenmaier, and P. Scheurich. 1995. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83: 793-802.
16. Ruuls, S. R., R. M. Hoek, V. N. Ngo, T. McNeil, L. A. Lucian, M. J. Janatpour, H. Korner, H. Scheerens, E. M. Hessel, J. G. Cyster, et al. 2001. Membranebound TNF supports secondary lymphoid organ structure but is subservient to secreted TNF in driving autoimmune inflammation. Immunity 15: 533-543.
17. Pakala, S. V., M. Chivetta, C. B. Kelly, and J. D. Katz. 1999. In autoimmune diabetes the transition from benign to pernicious insulitis requires an islet cell response to tumor necrosis factor α, J. Exp. Med. 189: 1053-1062.
18. Hasegawa, Y., K. Yokono, T. Taki, K. Amano, Y. Tominaga, R. Yoneda, N. Yagi, S. Maeda, H. Yagita, K. Okumura, et al. 1994. Prevention of autoimmune insulin-dependent diabetes in non-obese diabetic mice by anti-LFA-1 and anti-ICAM-1 mAb. Int. Immunol. 6: 831-838.
19. Berney, T., A. Pileggi, R. D. Molano, R. Poggioli, E. Zahr, C. Ricordi, and L. Inverardi. 2003. The effect of simultaneous CD 154 and LFA-1 blockade on the survival of allogeneic islet grafts in nonobese diabetic mice. Transplantation 76: 1669-1674.
20. Balasa, B., A. La Cava, K. Van Gunst, L. Mocnik, D. Balakrishna, N. Nguyen, L. Tucker, and N. Sarvetnick. 2000. A mechanism for IL-10-mediated diabetes in the nonobese diabetic (NOD) mouse: ICAM-1 deficiency blocks accelerated diabetes. J. Immunol. 165: 7330-7337.
21. Hanninen, A., I. Jaakkola, and S. Jaikanen. 1998. Mucosal addressin is required for the development of diabetes in nonobese diabetic mice. J. Immunol. 160: 6018-6025.
22. 7 integrin and mucosal addressin cell adhesion molecule-1 (MAdCAM-1) in the development of diabetes in obese diabetic mice. Diabetes 46: 1542-1547.
23. Cameron, M. J., G. A. Arreaza, M. Grattan, C. Meagher, S. Sharif, M. D. Burdick, R. M. Strieter, D. N. Cook, and T. L. Delovitch. 2000. Differential expression of CC chemokines and the CCR5 receptor in the pancreas is associated with progression to type I diabetes. J. Immunol. 165: 1102-1110.